Life Science Nation Newsletter  |  June 4, 2015  |  Issue 114

  The LSN Story   |   Investor Platform   |   Company Platform   |   RESI Conference   |   Fundraising Accelerator
Life Science Investor Mandates (May 28 - June 3)

Seeking Digital Health and Novel Therapeutic Opportunities

Seeking Global Opportunities in Brain Health

Seeking Early Stage Medical Device Investments Globally
Seeking Therapeutic, Diagnostic and Device Investment Opportunities
In This Issue

LSN Summer Chapter Series: Issue #2

Mandates Across Healthcare Silos

   READ MORE

RESI @ TMCx Partnering Breakdown: Who Is Meeting with Whom?

RESI Conference Group's Upcoming Events
LSN Videos
RESI 4 Recap Video, San Francisco, 2015
RESI 4 Investor Panel Videos

LSN Summer Chapter Series: Issue #2

By Scott Parks, Director of Marketing, LSN

Welcome to the second installment of the LSN Summer Chapter Series. This week we'll finish up the legal section of The Life Science Executive's Fundraising Manifesto by covering the rest of the necessary regulatory underpinnings for your fundraising campaign: how to market your offering and potentially tap the crowd for capital.

 

Chapter 2, "The Legal Landscape - Crowdfunding and IPOs," was contributed by Robert H. Cohen, Esq. This chapter provides a comprehensive look at the possibilities created for life science companies by the JOBS Act of 2012, including crowdfunding, publicizing a private offering under Regulation D, and new regulations for IPOs. Cohen takes the reader through the nuances of what is and is not permitted in terms of publicizing your offering, and also explains the different types of securities that might be offered...

 

Click here to download/print the PDF.
 

  READ MORE

Mandates Across Healthcare Silos

By Lucy Parkinson, Senior Research Manager, LSN  

 

This week, we are featuring four additional investor mandates, focused on Therapeutics, Medical Device, Diagnostics, and Healthcare IT. LSN Research has seen investors from all across the globe looking for investment opportunities and would like to share more of a sample of the types of information that we gather.

  

1. Therapeutics: US Based Venture Arm of Chinese Family Office Seeking Preclinical Biologic Opportunities

 

A private investment group that was founded by a single family out of Hong Kong has four operations based in Shanghai, Beijing, Hong Kong and the US. The US-based venture investment arm is actively seeking new investments in the life sciences across the US, and it occasionally invests in companies in Europe. The group focuses on pre-clinical and clinical stage companies. The investment size will vary and typically it ranges from $2 million -$10 million. The group has no set number of allocations over the next 6-9 months.

In the life sciences the firm is looking for new investments primarily in the biotech therapeutics sector. The group will also look at medical devices and diagnostics opportunities, however, which are not their current focuses. For therapeutics, the group is most interested in biologics. The group invests in a variety of therapeutic areas with a focus on oncology. The group generally invests in pre-clinical stage companies without clinical data, and it also syndicates with other investors for clinical-stage investments.

 

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com 

 

2. Medical Device: Family Office Fund Seeking Early Stage Medical Devices...

 

  READ MORE

RESI @ TMCx Partnering Breakdown: Who Is Meeting with Whom? 

By Michael Quigley, Director of Research, LSN 

 

With just a few days left until the RESI@TMCx kicks off, we wanted to take a look into the partnering system to see what kinds of meetings have been booked. So far, over 550 meetings have been set up through the system. The chart below (Figure 1) shows the meetings booked so far at RESI@TMCx by the types of organizations that are participating.

 

In total, 75% of the meetings booked so far are between investors and start-ups across the sectors of biotech therapeutics, medical devices, diagnostics, and healthcare IT. Start-up-investor meetings are the staple of the RESI conference. Enabled by LSN's proprietary investor data and partnering platform, these meetings are built around a fit between the company and investor to help foster meaningful connections and lasting relationships.

 

  READ MORE